Most Popular
1. THE INFLATION MONSTER is Forecasting RECESSION - Nadeem_Walayat
2.Why APPLE Could CRASH the Stock Market! - Nadeem_Walayat
3.The Stocks Stealth BEAR Market - Nadeem_Walayat
4.Inflation, Commodities and Interest Rates : Paradigm Shifts in Macrotrends - Rambus_Chartology
5.Stock Market in the Eye of the Storm, Visualising AI Tech Stocks Buying Levels - Nadeem_Walayat
6.AI Tech Stocks Earnings BloodBath Buying Opportunity - Nadeem_Walayat
7.PPT HALTS STOCK MARKET CRASH ahead of Fed May Interest Rate Hike Meeting - Nadeem_Walayat
8.50 Small Cap Growth Stocks Analysis to CAPITALISE on the Stock Market Inflation -Nadeem_Walayat
9.WE HAVE NO CHOICE BUT TO INVEST IN STOCKS AND HOUSING MARKET - Nadeem_Walayat
10.Apple and Microsoft Nuts Are About to CRACK and Send Stock Market Sharply Lower - Nadeem_Walayat
Last 7 days
UK Housing Market Analysis, Trend Forecast 2022 to 2025 - Part 2 - 30th June 22
Stock Market Turning the Screws - 30th June 22
How to Ignore Stocks (and why you should) - 30th June 22
Top Tips For Getting The Correct Insurance Option For Your Needs - 30th June 22
Central Banks Plan To Buy More Gold In 2022 - 30th June 22
AI Tech Stock PORTFOLIO NAME OF THE GAME - 29th June 22
Rebounding Crude Oil Gets Far Away from the Bearish Side - 29th June 22
UK House Prices - Lets Get Jiggy With UK INTEREST RATES - 28th June 22
GOLD STOCKS ARE WORSE THAN GOLD - 28th June 22
This “Bizarre” Chart is Wrecking the Stock Market - 28th June 22
Recession Question Answered - 28th June 22
Technical Analysis: Why You Should Expect a Popularity Surge - 28th June 22
Have US Bonds Bottomed? - 27th June 22
Gold Junior Miners: A Bearish Push Is Coming to Move Them Lower - 27th June 22
Stock Market Watching Out - 27th June 22
The NEXT BIG EMPIRE WILL BE..... CANZUK - 25th June 22
Who (or What) Is Really in Charge of Bitcoin's Price Swings? - 25th June 22
Crude Oil Price Forecast - Trend Breaks Downward – Rejecting The $120 Level - 25th June 22
Everyone and their Grandma is Expecting a Big Stocks Bear Market Rally - 23rd June 22
The Fed’s Hawkish Bite Left Its Mark on the S&P 500 Stocks - 23rd June 22
No Dodging the Stock Market Bullet - 23rd June 22
How To Set Up A Business To Better Manage In The Free Market - 23rd June 22
Why Are Precious Metals Considered A Good Investment? Find Out Here - 23rd June 22
UK House Prices and the Inflation Mega-trend - 22nd June 22
Sportsbook Betting Reviews: How to Choose a Sportsbook- 22nd June 22
Looking to buy Cannabis Stocks? - 22nd June 22
UK House Prices Momentum Forecast - 21st June 22
The Fed is Incompetent - Beware the Dancing Market Puppet - 21st June 22
US Economy Headed for a Hard Landing - 21st June 22
How to Invest in EU - New Opportunities Uncovered - 21st June 22
How To Protect Your Assets During Inflation - 21st June 22

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

Next Step: A Home Cancer Test Kit?

Stock-Markets / Healthcare Sector Jul 27, 2011 - 04:51 AM GMT

By: Doug_Horning

Stock-Markets

Best Financial Markets Analysis ArticleDoug Hornig, Casey Extraordinary Technology writes: With cancer, early detection equals a greater likelihood that treatment will have a positive outcome.

Physicians have known this for a long time, and the statistics back them up. Survival rates for those afflicted with many types of cancer have risen dramatically in the past few decades. And one of the primary reasons is that we are diagnosing cancer earlier and with much greater accuracy.


Not only are people more mindful about getting regular checkups, but diagnostic techniques have improved by leaps and bounds, as well.

In the not-too-distant past, the only way to get a close-up look at what was going on inside a patient’s body was via exploratory surgery, which is not unlike using a sledgehammer to drive a threepenny nail. There’s considerable collateral damage.

X-rays, which were discovered at the turn of the last century, added an important new tool to the diagnostic arsenal, and they remain the most common first option today. And there things stood until the 1970s, when the whole field suddenly exploded.

Ultrasound machines use sound waves to map internal body structures. They’re simple and cheap, provide immediate results, and don’t involve radiation. Though they’ve been around since 1950, they weren’t perfected until 1979, when they added computing technology for image enhancement.

Computed tomography (CAT) and positive emission tomography (PET) scans were also introduced in the ’70s. Both provide detailed maps of internal body structures, with CAT scans employing X-rays and PET scans gamma rays. Nowadays, CAT and PET scans are often performed in immediate sequence in the same session, and the results can be quickly correlated to provide very detailed views of moving organs, in three dimensions and real time.

The magnetic resonance imaging (MRI) machine was first studied on humans in 1977. An MRI scanner generates a powerful magnetic field that agitates atomic nuclei into giving off photons, which have frequencies that can be translated into an image.

Finally, needle aspiration biopsies -- which came to market in 1981 -- involve the removal of a small number of cells from a suspected problem area. They are minimally invasive, generally safe, and often the procedure of choice for examining potential tumors that lie just under the skin.

All of these tools are an improvement on cutting each patient open. Although each has its drawbacks as well as its benefits, they have comprised the physician’s options for the past thirty years. What has been missing is a diagnostic that reveals the presence of cancer, no matter where it is or what stage it’s at. Something, in other words, that will provide the earliest of early detections. And, oh yes, it should also be non-invasive and risk-free.

That’s the golden key, and though it may seem like asking for too much, doctors are close to having it in their hands.

Last December, in a paper published in Nature, researchers at the Massachusetts General Hospital Cancer Center revealed the results of tests with a new cancer blood test. The test uses microchip technology to sift blood to search for circulating tumor cells (CTCs), which come from solid tumors and roam through the blood.

CTCs are hard to find because they're rare, accounting for just one in a billion among cancer patients' blood cells. Yet the test homes in on them with great accuracy. Used on 116 cancer patients, including people with lung, breast, prostate, pancreatic, and colon cancers, the test spotted CTCs in the blood samples from 99% of them. It detected CTCs even when there were only 5 CTCs in a milliliter of blood. At the same time, the test returned no false positives in blood samples from 20 healthy people.

The test requires only a couple of teaspoons of blood, and doctors initially want to put it to work providing instant feedback on whether a particular therapy is or is not working. Most exciting, though, is its potential for early diagnosis. Although researchers stress that a great deal of work remains to be done, providing cancer screenings as a routine part of one’s conventional blood workup seems like an attainable goal.

This is such a breakthrough that Johnson & Johnson immediately announced it was throwing its considerable resources behind the effort to bring the test to market. And four major cancer research centers in the U.S. have signed on to do follow-up research this year.

A home cancer test kit? No, that’s not even on the horizon as yet. But the possibility can now be imagined. And technology has repeatedly demonstrated that what can be imagined can eventually be created.

Recently, the Casey Technology team added five biotech companies with breakthrough cancer treatments to its portfolio – innovative technologies that could save millions of lives and make investors handsome returns in the process.

© 2011 Copyright Casey Research - All Rights Reserved

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.


© 2005-2019 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in